~" The complications associated with 92 dorsal column stimulator implants are reported. They were of two types, technical and functional. In all there were 58 significant complications. Most technical complications were correctable but complications difficult to correct occurred in 26 patients. Late failure in stimulation was observed in 32 implants that had given excellent pain control for periods ranging from months to years. Improvements in the results of this procedure may be achieved by future technical developments and by clarification of physiological mechanisms.
In 84 patients, 92 dorsal column stimulator implants were performed over a 4-year period. The criteria for selection of patients for this procedure are described in other publications, 4,e,7 and include physical examination, characteristics of pain, Minnesota Multiphasic Personality Inventory (MMPI) evaluation, and transcutaneous electrical stimulation.
Sixty-eight implants were performed to treat chronic intractable pain 4 due to disc operation failure in 60 patients, and 24 implants were inserted for miscellaneous pain in 24 patients (Table 1) . Good results were obtained from 32 (47%) of the implants for disc operation failures, and in 11 (45%) of the miscellaneous group (causalgia, traumatic neuroma, Paget's disease, and others).
To reduce the incidence of wound infections and meningitis, preoperative, intraoperative, and postoperative antibiotics were given. In addition to sterilization, the dorsal column stimulator was soaked in Garamycin (gentamicin) solution before insertion. The implant was placed with particular care in order to prevent paraparesis and paralysis; placement in an unusually narrow spinal canal was generally avoided. Furthermore, the dural incision was closed with minimal overlap of edges over the dorsal column stimulator plate, to prevent narrowing of the subdural space and to avoid compression of the spinal cord. Approximately equal numbers of unipolar and bipolar electrodes were implanted. 
Cause of Implant

Results
Complications seen in this series were classified as 1) technical; 2) functional, or delayed; and 3) miscellaneous ( Table 2) . (Tables 2 and 3 ) according to the type of procedure needed to correct the complication.
Technical Complications
In the minor group, transitory pain at the site of the implant in the laminectomy wound or at the receiver site could be controlled with a local Xylocaine (lidocaine) block. Leakage of CSF was usually found to be correctable by re-opening the wound and reinforcing it with muscle; a watertight closure using a purse-lock stitch s around the stem of the electrode was used. In two patients, leakage of CSF ceased spontaneously. In three patients, pseudomeningoceles were found when surgery was performed for correction of the CSF leakage. Pseudomeningoceles were easily correctable. Often pseudoseromas present at the receiver site resulted from the seepage of CSF through the electrode lead wire into the pocket for the receiver. These were controlled with aspiration.
In the major group of correctable complications, a major surgical repair was required. It was evident that significant arachnoid thickening and organized membrane formation interrupted or shunted current flow away from the target tissue. This shift of the stimulation away from the affected area required either discontinuance of stimulation, or the replacement or repositioning of the electrode. In acute maldistribution of stimulation, it was clear that immediate repositioning of the electrode was needed.
Uncorrectable Complications. Uncorrectable technical complications are those that are difficult to correct, or in which correction is not compatible with continuation of the electroanalgesia. These complications include organized membrane formation, and misdirected stimulation. We have encountered no acute paraplegia, meningitis, or laminectomy wound infections.
Eight (9%) serious complications required removal of the dorsal column stimulator as a result of extrusion of the lead wire and infection of the receiver site, or localized severe pain. The extrusion of the lead wire near the receiver 11/~ years after one implantation was followed by Staphylococcal infection and required removal, despite the fact that the stimulation was controlling pain. The lead wire was just subcutaneous and with time it eroded through the skin to the surface. Infection quickly followed this exposure. In another case, an infection developed at the site of the receiver almost 21/2 years after surgery. The pathogen (Staphylococcus aureus) seems to have been sequestered in the instrument. The patient was given antibiotic therapy and the implant was removed.
In one case, continued leakage of CSF despite repeated surgical repairs necessitated removal of the stimulator; excellent relief had been obtained until removal of the implant. A third complication in this category of uncorrectable complications was that of radiculitis with unbearable pain, requiring removal of the implanted device. This complication resulted from electrode placement in a patient with an unusually narrow spinal canal. Further complications related to the connecting wire have been reported by Fox, 1 who noted that breaks sometimes occurred in the lead wire during revision. The final complication in this series was the spontaneous shifting of the electrode from an intradural to an extradural position (one case).
Functional Failures of Stimulation
Eventually 32 (34%) of the 92 implants (Table 4) failed to provide stimulation sufficient to relieve pain, either because no stimulus was delivered or because they evoked unpleasant paresthesias. Such delayed failures occurred on the average 9 months after placement for unipolar, and 14 months postoperatively for bipolar implants. 
Miscellaneous Complications
One patient, although he initially had obtained excellent relief of pain, noted a change from a pleasant sensation to an unpleasant gross stimulation in his right leg, the site of his pain. This patient persisted in using the stimulation and developed an extensive ulcerative dermatosis that disappeared after the patient eventually discontinued stimulation. The role of chronic stimulation in producing trophic changes of the skin could not be determined.
Two patients developed a progressive paraparesis with no evidence of arachnoiditis at the site of the electrode, and with no indication of progression of the original pathology. Although both patients were advised to discontinue the stimulation, they persisted in using it, because "they could not live with their pain." At this writing, these patients are still using their stimulators. Although their mobility is impaired (one patient is in a wheelchair and the other is walking but using a cane), they are in complete control of their 
Discussion
Complications resulting from the use of the dorsal column stimulator result from the operative procedure or from later changes in the delivery of the stimulus (Table 5) . Most of the complications in this series were surgically correctable. The highest incidence of late failures occurred with unipolar electrodes. Delayed failure and dysesthesias are caused by adhesive arachnoiditis, a spreading or shunting of the current to other areas of the spinal cord, 2 and possibly by changes in neuronal circuitry.
No data are available at present to indicate whether damage is induced through extended stimulation at normal parameters. Pudenz, et al.? postulated that damage could result from neuronal injury, local hypoxia, and bloodbrain barrier alteration permitting escape of neural toxic substances from the blood vessels. Any or all of these mechanisms could interfere with neural function. In two of our patients, who both obtained excellent relief of pain, paraparesis ensued, but myelographic studies failed to demonstrate any local compression in the absence of arachnoiditis. Possible tissue injury could be explained as resulting from long-term stimulation producing direct injury or damage to the neurons. Pudenz, et al., 5 in studying the effect of neural stimulation found that current flow is more important than electrical chemical reaction in producing irreversible neuron damage.
There appears to be a place for the use of the dorsal column stimulator, but further clarification of the physiological mechanism of pain relief by this means is required. The incidence of complications can be reduced if appropriate steps are employed in the implanting procedure. Table 3 ).
